ARTICLE | Clinical News
Narcan naloxone regulatory update
October 19, 2015 7:00 AM UTC
FDA accepted and granted Priority Review to an NDA from Adapt for Narcan naloxone Nasal Spray to treat opioid overdose. The PDUFA date is in early 2016. Adapt has worldwide rights to develop and comm...